EMA Chief: ‘Safety Is Our Priority’ In Review Of COVID-19 Vaccine
Data To Be Made Available Quickly After Approval
The EMA says its experts are working “around the clock” on a recommendation for conditional marketing authorization of a COVID-19 vaccine, but that it will only OK a vaccine if it is satisfied that the evidence convincingly shows the benefits are greater than the risks.
